Allergy/Asthma News

Individuals who had an immediate allergic reaction to a first SARS-CoV-2 mRNA vaccine showed a low risk for an immediate or severe allergic reaction following the second dose, according to results of a systemic review and meta-analysis.

House dust mite sublingual immunotherapy tablets reduced inhaled corticosteroid use among patients with mild to moderate allergic asthma, according to a systematic review in The Journal of Allergy and Clinical Immunology: In Practice.

Sex and gender can influence the pathogenesis, clinical course, diagnosis, treatment and management of asthma, according to a review published in The Journal of Allergy and Clinical Immunology: In Practice.

David A. Khan, MD, FAAAAI, of University of Texas Southwestern Medical Center, will be installed as president of the American Academy of Allergy, Asthma & Immunology during its annual meeting Feb. 25 to 28 in Phoenix.

Delayed hypersensitivity to vaccines is not uncommon but also does not typically contraindicate further vaccination, and patch testing can be used to determine the cause, according to a study published in Allergy & Asthma Proceedings.

Children with atopic dermatitis generally experienced the most intense itching in the early evening or bedtime, approximately 3 hours before they fell asleep, according to a study published in Annals of Allergy, Asthma & Immunology.

A dose of omalizumab administered before pollen season improved symptom control and quality of life compared with standard medication among patients with seasonal allergic rhinitis, according to a study in Clinical and Translational Allergy.

Approximately one in 40 items purchased at bakeries in the New York and Miami metropolitan areas contained unintended peanut protein, according to a study published in Annals of Allergy, Asthma & Immunology.

Pediatric allergy clinics can use telemedicine to increase accessibility, with subsequent in-person visits scheduled for necessary testing, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Omalizumab benefited patients with moderate to severe allergic asthma regardless of their BMI, according to a study published in Annals of Allergy, Asthma & Immunology.